These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 471816)

  • 1. [Evaluation of porphyrogenic action of selected drugs].
    Kostrzewska E; Gregor A; Traczyk A
    Pol Tyg Lek; 1979 May; 34(21):817-9. PubMed ID: 471816
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute intermittent porphyria and drugs].
    Myhre E; Lunde KM
    Tidsskr Nor Laegeforen; 1976 Nov; 92(33):1749. PubMed ID: 996840
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic factors in adverse drug reactions.
    Kalow W
    Int Z Klin Pharmakol Ther Toxikol; 1971 Aug; 5(1):38-42. PubMed ID: 5570061
    [No Abstract]   [Full Text] [Related]  

  • 4. Some of the clinically more important side effects of drug therapy. Part 2.
    Rowe WS
    Med J Aust; 1975 Apr; 1(16):506-8. PubMed ID: 1079559
    [No Abstract]   [Full Text] [Related]  

  • 5. Herbicide-induced experimental variegate porphyria in mice: tissue porphyrinogen accumulation and response to porphyrogenic drugs.
    Krijt J; Stranska P; Maruna P; Vokurka M; Sanitrak J
    Can J Physiol Pharmacol; 1997; 75(10-11):1181-7. PubMed ID: 9431441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anesthetic considerations of porphyria.
    Wright YG; Parvata CP
    AANA J; 1981 Feb; 49(1):55-8. PubMed ID: 7234314
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-induced uroporphyria in chicken hepatocyte cultures.
    Ferioli A; Harvey C; De Matteis F
    IARC Sci Publ; 1986; (77):465-6. PubMed ID: 3596741
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hazards in therapy of the porphyric patient].
    Pellat B; Cornebise C; Deybach JC
    Inf Dent; 1989 Sep; 71(33):2967, 2971-5. PubMed ID: 2534758
    [No Abstract]   [Full Text] [Related]  

  • 9. Disturbances of liver porphyrin metabolism caused by drugs.
    de Matteis F
    Pharmacol Rev; 1967 Dec; 19(4):523-57. PubMed ID: 4868613
    [No Abstract]   [Full Text] [Related]  

  • 10. [The hepatic porphyrias].
    Schenk J
    Fortschr Med; 1978 Jun; 96(22):1167-70. PubMed ID: 658867
    [No Abstract]   [Full Text] [Related]  

  • 11. Porphyrogenic activity of methsuximide and its demethylated metabolite.
    Orton TC; Nicholls PJ
    J Pharm Pharmacol; 1972 Feb; 24(2):151-2. PubMed ID: 4401970
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of the rat in the experimental investigation of the porphyrias.
    Eales L; Blekkenhorst GH
    J S Afr Vet Assoc; 1978 Sep; 49(3):249-51. PubMed ID: 745206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative abilities on a molar basis of hexafluoro-, hexachloro- and hexabromobenzenes to decrease liver uroporphyrinogen decarboxylase activity and cause porphyria in female rats.
    Smith AG; Francis JE
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):377-84. PubMed ID: 7394329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs and the hepatic porphyrias.
    Smith AG; De Matteis F
    Clin Haematol; 1980 Jun; 9(2):399-425. PubMed ID: 7398153
    [No Abstract]   [Full Text] [Related]  

  • 15. [International cooperation of the porphyria commission: prohibited and permitted drugs in acute hepatic porphyria].
    Doss M; Wetterberg L
    Fortschr Med; 1977 Nov; 95(42):2531-3. PubMed ID: 914210
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study on the mechanism of action of glucose on excessive biosynthesis of porphyrins in rats].
    Gajdos A; Gajdos-Török M
    Rev Eur Etud Clin Biol; 1972; 17(7):708-14. PubMed ID: 4346549
    [No Abstract]   [Full Text] [Related]  

  • 17. Electron-microscopic changes in the livers of mice treated with the porphyrinogenic agent 1,4-dihydro-3,5-dicarbethoxycollidine.
    Waterfield MD; Del Favero A; Palfrey AJ
    J Pathol; 1969 Jun; 98(2):151-4. PubMed ID: 5352371
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adverse effects of drugs. 11. Liver function and adverse effects of drugs].
    Tamura T
    Kango; 1973 Dec; 25(12):118-9. PubMed ID: 4494072
    [No Abstract]   [Full Text] [Related]  

  • 19. [Exogenous inductors in the clinical manifestations of hepatic porphyria].
    Horváth T; Mándy I; Vezekényi Z; Simon K; Jávor T
    Orv Hetil; 1976 Jun; 117(24):1447-51. PubMed ID: 934636
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Griseofulvin on 5-aminolevulinate synthase and on ferrochelatase in mouse liver neoplastic nodules.
    Denk H; Kalt R; Abdelfattach-Gad M; Meyer UA
    Cancer Res; 1981 Apr; 41(4):1535-8. PubMed ID: 7214331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.